Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
暂无分享,去创建一个
C. Yiannoutsos | F. Tanser | K. Wools-Kaloustian | R. Wood | N. de Rekeneire | G. Wandeler | M. Davies | I. Sikazwe | A. Boulle | M. Fox | V. Leroy | J. Bor | A. Brennan | H. Prozesky | G. Fatti | K. Stinson